Petit, M.; Walet-Balieu, M.-L.; Schapman, D.; Golinski, M.-L.; Burel, C.; Barray, M.; Drouot, L.; Maho-Vaillant, M.; Hébert, V.; Boyer, O.;
et al. Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment. Biomedicines 2021, 9, 1411.
https://doi.org/10.3390/biomedicines9101411
AMA Style
Petit M, Walet-Balieu M-L, Schapman D, Golinski M-L, Burel C, Barray M, Drouot L, Maho-Vaillant M, Hébert V, Boyer O,
et al. Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment. Biomedicines. 2021; 9(10):1411.
https://doi.org/10.3390/biomedicines9101411
Chicago/Turabian Style
Petit, Marie, Marie-Laure Walet-Balieu, Damien Schapman, Marie-Laure Golinski, Carole Burel, Marion Barray, Laurent Drouot, Maud Maho-Vaillant, Vivien Hébert, Olivier Boyer,
and et al. 2021. "Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment" Biomedicines 9, no. 10: 1411.
https://doi.org/10.3390/biomedicines9101411
APA Style
Petit, M., Walet-Balieu, M.-L., Schapman, D., Golinski, M.-L., Burel, C., Barray, M., Drouot, L., Maho-Vaillant, M., Hébert, V., Boyer, O., Bardor, M., Joly, P., & Calbo, S.
(2021). Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment. Biomedicines, 9(10), 1411.
https://doi.org/10.3390/biomedicines9101411
